What does CUSIP 92764N102 represent in this 13F holders report?

CUSIP 92764N102 is the security identifier for VIR - Vir Biotechnology, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held VIR - Vir Biotechnology, Inc. - COMMON STOCK in Q1 2023?

226 institutional investors reported VIR - Vir Biotechnology, Inc. - COMMON STOCK for Q1 2023. Use the holders table for investor-level position and value details.

Vir Biotechnology, Inc. - COMMON STOCK (VIR)

CUSIP: 92764N102

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COMMON STOCK
Total 13F shares: 88,385,448
Total 13F value: $2,056,730,043
Share change: +2,390,719
Put/Call ratio: 67%
SEC-reported price per share: $23.27
Number of holders: 226
Value change: +$54,021,550
Number of buys: 114
Number of sells: 99
Shares outstanding: 168,883,915

Security key

92764N102

Report period

Q1 2023

Institutions

226

Top holders

VIR full security history Ownership snapshot Full 13F holder table Vir Biotechnology, Inc. SEC filings Vir Biotechnology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of VIR - Vir Biotechnology, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SB INVESTMENT ADVISERS (U...

Disclosed value leader

SB INVESTMENT ADVISERS (U...

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.

Comparable ownership Top 5

SB INVESTMENT ADVISERS (UK) LTD 12%

BlackRock Finance, Inc. 8.4%

VANGUARD GROUP INC 6%

Temasek Holdings (Private) Ltd 3.4%

STATE STREET CORP 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SB INVESTMENT ADVISERS (UK) LTD	13F Company 13F	12%	$512,768,831 20,259,535 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	8.4%	$357,798,054 14,136,628 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	6%	$255,491,820 10,094,501 shares	—	31 Dec 2022
Temasek Holdings (Private) Ltd	13F Company 13F	3.4%	$144,533,008 5,710,510 shares	—	31 Dec 2022
STATE STREET CORP	13F Company 13F	3.2%	$138,609,127 5,476,457 shares	—	31 Dec 2022
BAILLIE GIFFORD & CO	13F Company 13F	2.4%	$100,850,251 3,984,601 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

226

88,385,448

Rows available

226

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

226

Q1 2023 holders

226

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %